• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家庭医学中的 COVID-19 评估-基于自我评估症状和接触史的临床决策规则。

COVID-19 assessment in family practice-A clinical decision rule based on self-rated symptoms and contact history.

机构信息

TUM School of Medicine, Institute of General Practice and Health Services Research, Technical University of Munich, Munich, Germany.

TUM School of Medicine, Institute of Medical Informatics, Statistics and Epidemiology, Technical University Munich, Munich, Germany.

出版信息

NPJ Prim Care Respir Med. 2021 Nov 25;31(1):46. doi: 10.1038/s41533-021-00258-4.

DOI:10.1038/s41533-021-00258-4
PMID:34824286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8617029/
Abstract

The study aimed to evaluate the diagnostic accuracy of contact history and clinical symptoms and to develop decision rules for ruling-in and ruling-out SARS-CoV-2 infection in family practice. We performed a prospective diagnostic study. Consecutive inclusion of patients coming for COVID-PCR testing to 19 general practices. Contact history and self-reported symptoms served as index test. PCR testing of nasopharyngeal swabs served as reference standard. Complete data were available from 1141 patients, 605 (53.0%) female, average age 42.2 years, 182 (16.0%) COVID-PCR positive. Multivariable logistic regression showed highest odds ratios (ORs) for "contact with infected person" (OR 9.22, 95% CI 5.61-15.41), anosmia/ageusia (8.79, 4.89-15.95), fever (4.25, 2.56-7.09), and "sudden disease onset" (2.52, 1.55-4.14). Patients with "contact with infected person" or "anosmia/ageusia" with or without self-reported "fever" had a high probability of COVID infection up to 84.8%. Negative response to the four items "contact with infected person, anosmia/ageusia, fever, sudden disease onset" showed a negative predictive value (NPV) of 0.98 (95% CI 0.96-0.99). This was present in 446 (39.1%) patients. NPV of "completely asymptomatic," "no contact," "no risk area" was 1.0 (0.96-1.0). This was present in 84 (7.4%) patients. To conclude, the combination of four key items allowed exclusion of SARS-CoV-2 infection with high certainty. With the goal of 100% exclusion of SARS-CoV-2 infection to prevent the spread of SARS-CoV-2 to the population level, COVID-PCR testing could be saved only for patients with negative response in all items. The decision rule might also help for ruling-in SARS-CoV-2 infection in terms of rapid assessment of infection risk.

摘要

这项研究旨在评估接触史和临床症状的诊断准确性,并制定用于家庭实践中排除和确诊 SARS-CoV-2 感染的决策规则。我们进行了一项前瞻性诊断研究。连续纳入了 19 家普通诊所前来进行 COVID-PCR 检测的患者。接触史和自我报告的症状作为指标测试。鼻咽拭子的 PCR 检测作为参考标准。共有 1141 名患者的完整数据可用,其中 605 名(53.0%)为女性,平均年龄为 42.2 岁,182 名(16.0%)COVID-PCR 检测呈阳性。多变量逻辑回归显示,“与感染者接触”(优势比 9.22,95%置信区间 5.61-15.41)、嗅觉丧失/味觉丧失(8.79,4.89-15.95)、发热(4.25,2.56-7.09)和“疾病突然发作”(2.52,1.55-4.14)的比值最高。有“与感染者接触”或“嗅觉丧失/味觉丧失”或伴有自我报告“发热”的患者,COVID 感染的可能性高达 84.8%。四项“与感染者接触、嗅觉丧失/味觉丧失、发热、疾病突然发作”的阴性反应显示出 0.98(95%置信区间 0.96-0.99)的阴性预测值(NPV)。446 名(39.1%)患者符合这一条件。完全无症状、无接触、无风险地区的 NPV 为 1.0(0.96-1.0)。84 名(7.4%)患者符合这一条件。总之,四项关键项目的结合可以高度确定地排除 SARS-CoV-2 感染。如果目标是 100%排除 SARS-CoV-2 感染以防止 SARS-CoV-2 在人群水平上传播,那么只有对所有项目均无反应的患者才可以进行 COVID-PCR 检测。该决策规则也可以帮助快速评估感染风险,从而确定 SARS-CoV-2 感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/8617029/7c11448a39ca/41533_2021_258_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/8617029/01599771b3a3/41533_2021_258_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/8617029/adc7b0b83bfb/41533_2021_258_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/8617029/7c11448a39ca/41533_2021_258_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/8617029/01599771b3a3/41533_2021_258_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/8617029/adc7b0b83bfb/41533_2021_258_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b00/8617029/7c11448a39ca/41533_2021_258_Fig3_HTML.jpg

相似文献

1
COVID-19 assessment in family practice-A clinical decision rule based on self-rated symptoms and contact history.家庭医学中的 COVID-19 评估-基于自我评估症状和接触史的临床决策规则。
NPJ Prim Care Respir Med. 2021 Nov 25;31(1):46. doi: 10.1038/s41533-021-00258-4.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
3
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对远程早期检测 SARS-CoV-2 感染(COVID-RED)的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jun 22;22(1):412. doi: 10.1186/s13063-021-05241-5.
4
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对 SARS-CoV-2 感染(COVID-RED)的远程早期检测的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5.
5
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
6
The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.美国路易斯安那州社区有症状和无症状 SARS-CoV-2 感染患者出现嗅觉丧失、味觉丧失和年龄的重要性;一项横断面患病率研究。
Clin Microbiol Infect. 2021 Apr;27(4):633.e9-633.e16. doi: 10.1016/j.cmi.2020.12.029. Epub 2021 Jan 6.
7
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.社区人群中与新型冠状病毒感染相关的症状和症状群:一项全州范围流行病学研究的结果
medRxiv. 2020 Oct 22:2020.10.11.20210922. doi: 10.1101/2020.10.11.20210922.
8
COVID-19 symptoms predictive of healthcare workers' SARS-CoV-2 PCR results.COVID-19 症状可预测医护人员的 SARS-CoV-2 PCR 结果。
PLoS One. 2020 Jun 26;15(6):e0235460. doi: 10.1371/journal.pone.0235460. eCollection 2020.
9
Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.在六个国家数字监测平台上,与 SARS-CoV-2 检测呈阳性相关的嗅觉丧失、味觉丧失和其他类似 COVID-19 的症状:一项观察性研究。
Lancet Digit Health. 2021 Sep;3(9):e577-e586. doi: 10.1016/S2589-7500(21)00115-1. Epub 2021 Jul 22.
10
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.羟氯喹预防 SARS-CoV-2 感染和妊娠期 COVID-19 疾病严重程度的疗效和安全性(COVID-Preg):一项随机安慰剂对照试验研究方案的结构化总结。
Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.

引用本文的文献

1
Identifying Existing Evidence to Potentially Develop a Machine Learning Diagnostic Algorithm for Cough in Primary Care Settings: Scoping Review.识别现有证据,以潜在开发用于初级保健环境中咳嗽的机器学习诊断算法:范围综述。
J Med Internet Res. 2023 Dec 14;25:e46929. doi: 10.2196/46929.

本文引用的文献

1
Cross sectional study of the clinical characteristics of French primary care patients with COVID-19.法国初级保健科 COVID-19 患者的临床特征横断面研究。
Sci Rep. 2021 Jun 14;11(1):12492. doi: 10.1038/s41598-021-91685-3.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
3
Rapid coronavirus tests: a guide for the perplexed.
快速冠状病毒检测:给困惑者的指南。
Nature. 2021 Feb;590(7845):202-205. doi: 10.1038/d41586-021-00332-4.
4
Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases.消除可能是应对新冠疫情及其他新出现的大流行疾病的最佳应对策略。
BMJ. 2020 Dec 22;371:m4907. doi: 10.1136/bmj.m4907.
5
The challenges of containing SARS-CoV-2 via test-trace-and-isolate.通过检测-追踪-隔离来控制 SARS-CoV-2 面临的挑战。
Nat Commun. 2021 Jan 15;12(1):378. doi: 10.1038/s41467-020-20699-8.
6
Risk factors for a positive SARS-CoV-2 PCR in patients with common cold symptoms in a primary care setting - a retrospective analysis based on a joint documentation standard.在基层医疗机构中,以联合文件标准为基础,对普通感冒症状患者 SARS-CoV-2 PCR 阳性的危险因素进行回顾性分析。
BMC Fam Pract. 2020 Dec 3;21(1):251. doi: 10.1186/s12875-020-01322-7.
7
The Need for More and Better Testing for COVID-19.对新冠病毒进行更多更好检测的必要性。
JAMA. 2020 Dec 1;324(21):2153-2154. doi: 10.1001/jama.2020.21694.
8
Community seroprevalence of COVID-19 in probable and possible cases at primary health care centres in Spain.西班牙基层医疗中心可能病例和疑似病例的 COVID-19 社区血清流行率。
Fam Pract. 2021 Mar 29;38(2):154-159. doi: 10.1093/fampra/cmaa096.
9
Comparison of Epidemiological Variations in COVID-19 Patients Inside and Outside of China-A Meta-Analysis.比较中国境内外 COVID-19 患者的流行病学变化:一项荟萃分析。
Front Public Health. 2020 May 8;8:193. doi: 10.3389/fpubh.2020.00193. eCollection 2020.
10
Self-Reported Loss of Smell and Taste in SARS-CoV-2 Patients: Primary Care Data to Guide Future Early Detection Strategies.新冠病毒患者自我报告的嗅觉和味觉丧失:用于指导未来早期检测策略的基层医疗数据
J Gen Intern Med. 2020 Aug;35(8):2502-2504. doi: 10.1007/s11606-020-05933-9. Epub 2020 Jun 9.